Not just old wine in new bottles: Polygenic liability for ADHD is associated with electrophysiological affective-motivational processing beyond anxiety, depression, and ODD
- PMID: 40555725
- PMCID: PMC12187935
- DOI: 10.1038/s41398-025-03434-z
Not just old wine in new bottles: Polygenic liability for ADHD is associated with electrophysiological affective-motivational processing beyond anxiety, depression, and ODD
Abstract
In attention-deficit/hyperactivity disorder (ADHD), emotional features account for heterogeneity and exacerbate severity of behavioral and functional impairments, beyond cognitive and comorbidity features. Yet, debate remains about the extent to which, in ADHD, such emotional features are a "core feature", i.e. whether ADHD should be conceptualized as encompassing difficulties with regulating not only activity, attention, and impulses but also processing and regulating emotions. We aimed to address this issue by examining the extent to which in adolescents, ADHD polygenic scores (PGSs) are associated with electrophysiological indices of affective-motivational processing, measured during a monetary punishment/reward feedback paradigm. ADHD PGSs were negatively associated, in n = 166 adolescents (Mage = 15.76 years, SD = 1.07; 42.77% girls), with amplitude values of an occipitoparietal event-related potential (i.e. late positive potential) and were positively associated, in n = 84 adolescents (Mage = 15.76 years, SD = 1.05; 41.67% girls), with fronto-centro-parietal alpha event-related desynchronization. Across analyses, covariates were anxiety, depression, and ADHD with comorbid disruptive behavior disorder PGSs; ADHD, internalizing, and oppositional defiant disorder severity; childhood maltreatment; current ADHD medication; and baseline values of the outcome. Findings were replicated in sensitivity analyses with blocks of conceptually related covariates entered separately. In adolescents, electrophysiological indices of affective-motivational processing are associated principally with genetic liability for ADHD but not comorbidity genetic liability or comorbidity manifest symptoms.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: The authors declare no competing interests. Ethical standards: The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. Dedication: This work is dedicated to the memory of the late William Pelham Jr. As a doctoral student, in 2010, NB presented her ideas on emotion dysregulation and ADHD to Dr. Pelham, who challenged them, asking whether emotion dysregulation in ADHD was “nothing but old wine in new bottles.” His questioning became a catalyst, inspiring NB’s program of research—culminating in this manuscript—designed to establish a different perspective.
Figures



Similar articles
-
Electrophysiological indices of reward anticipation as ADHD risk and prognostic biomarkers.Eur Child Adolesc Psychiatry. 2025 Jun;34(6):1905-1916. doi: 10.1007/s00787-024-02606-4. Epub 2024 Nov 8. Eur Child Adolesc Psychiatry. 2025. PMID: 39516266 Free PMC article.
-
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003018. doi: 10.1002/14651858.CD003018.pub3. Cochrane Database Syst Rev. 2011. PMID: 22161373 Free PMC article.
-
Atypical antipsychotics for disruptive behaviour disorders in children and youths.Cochrane Database Syst Rev. 2012 Sep 12;(9):CD008559. doi: 10.1002/14651858.CD008559.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2017 Aug 09;8:CD008559. doi: 10.1002/14651858.CD008559.pub3. PMID: 22972123 Updated.
-
Cognitive-behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults.Cochrane Database Syst Rev. 2018 Mar 23;3(3):CD010840. doi: 10.1002/14651858.CD010840.pub2. Cochrane Database Syst Rev. 2018. PMID: 29566425 Free PMC article.
-
Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.Cochrane Database Syst Rev. 2022 Jul 13;7(7):CD013136. doi: 10.1002/14651858.CD013136.pub2. Cochrane Database Syst Rev. 2022. PMID: 35844168 Free PMC article.
References
-
- Junghänel M, Thöne A-K, Ginsberg C, Görtz-Dorten A, Frenk F, Mücke K, et al. Irritability and emotional impulsivity as core feature of ADHD and ODD in children. J Psychopathol Behav Assess. 2022;44:679–97.
MeSH terms
Grants and funding
- LP2018-3/2018/Magyar Tudományos Akadémia (Hungarian Academy of Sciences)
- HAS-ELRN NAP2022-I-2/2022/Magyar Tudományos Akadémia (Hungarian Academy of Sciences)
- LP2018-3/2018/Magyar Tudományos Akadémia (Hungarian Academy of Sciences)
- LP2018-3/2018/Magyar Tudományos Akadémia (Hungarian Academy of Sciences)
- HAS-ELRN NAP2022-I-2/2022/Magyar Tudományos Akadémia (Hungarian Academy of Sciences)
LinkOut - more resources
Full Text Sources
Medical